Citations (50)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Bruno P Imbimbo. (2009) An update on the efficacy of non-steroidal anti-inflammatory drugs in Alzheimer's disease. Expert Opinion on Investigational Drugs 18:8, pages 1147-1168.
Read now
Read now
Georgia B McGaughey & M Katharine Holloway. (2007) Structure-guided design of β-secretase (BACE-1) inhibitors. Expert Opinion on Drug Discovery 2:8, pages 1129-1138.
Read now
Read now
Roberto Scatena, Giuseppe E Martorana, Patrizia Bottoni, Giorgia Botta, Paola Pastore & Bruno Giardina. (2007) An update on pharmacological approaches to neurodegenerative diseases. Expert Opinion on Investigational Drugs 16:1, pages 59-72.
Read now
Read now
Articles from other publishers (47)
Isis Máximo Dantas Feitosa, Ronnie Emanuel Pereira Pinto, Matheus Mendonça Pereira, Cleide Mara Faria Soares & Álvaro Silva Lima. (2023) Extraction of protein with protease inhibitor activity from Brazilwood (Caesalpinia echinata LAM.) seeds using choline-based ionic liquids. Sustainable Chemistry and Pharmacy 31, pages 100956.
Crossref
Crossref
Deepan Chowdhury, Suman Dana, Subhankar Maity & Mahiuddin Baidya. (2020) Ruthenium-Catalyzed Site-Selective C–H Bond Activation/Annulation Cascade toward Dibenzoazepinone Skeletons. Organic Letters 22:17, pages 6760-6764.
Crossref
Crossref
Sukhen Karmakar, Vijay Byri, Ashvinikumar V. Gavai, Richard Rampulla, Arvind Mathur & Anuradha Gupta. (2016)
Crystallization-Induced Dynamic Resolution toward the Synthesis of (
S
)-7-Amino-5
H
,7
H
-dibenzo[
b
,
d
]-azepin-6-one: An Important Scaffold for γ-Secretase Inhibitors
. Organic Process Research & Development 20:10, pages 1717-1720.
Crossref
Crossref
Peng Bai, Xing-Fen Huang, Guo-Dong Xu & Zhi-Zhen Huang. (2016) Cascade C–H Functionalization/Amidation Reaction for Synthesis of Azepinone Derivatives. Organic Letters 18:13, pages 3058-3061.
Crossref
Crossref
Brian Marples, Mackenzie McGee, Sean Callan, Scott E. Bowen, Bryan J. Thibodeau, Daniel B. Michael, George D. Wilson, Michael E. Maddens, James Fontanesi & Alvaro A. Martinez. (2016) Cranial irradiation significantly reduces beta amyloid plaques in the brain and improves cognition in a murine model of Alzheimer?s Disease (AD). Radiotherapy and Oncology 118:1, pages 43-51.
Crossref
Crossref
Veronica Sandgren, Oscar Belda, Ingemar Kvarnström, Jimmy Lindberg, Bertil Samuelsson & Anders Dahlgren. (2015) Design and Synthesis of Novel Arylketo-containing P1-P3 Linked Macro-cyclic BACE-1 Inhibitors. The Open Medicinal Chemistry Journal 9:1, pages 13-26.
Crossref
Crossref
Luiz Miguel Camargo, Xiaohua Douglas Zhang, Patrick Loerch, Ramon Miguel Caceres, Shane D. Marine, Paolo Uva, Marc Ferrer, Emanuele de Rinaldis, David J. Stone, John Majercak, William J. Ray, Chen Yi-An, Mark S. Shearman & Kenji Mizuguchi. (2015) Pathway-Based Analysis of Genome-Wide siRNA Screens Reveals the Regulatory Landscape of App Processing. PLOS ONE 10:2, pages e0115369.
Crossref
Crossref
Yan Lv, Jianbin Zhang, Hao Wu, Shan Zhao, Yizhe Song, Shujun Wang, Bing Wang, Guojun Lv & Xiaojun Ma. (2015) A protease inhibition strategy based on acceleration of autolysis. Chemical Communications 51:27, pages 5959-5962.
Crossref
Crossref
Seema Jagota & Jayakumar Rajadas. (2012) Synthesis of d-amino acid peptides and their effect on beta-amyloid aggregation and toxicity in transgenic Caenorhabditis elegans. Medicinal Chemistry Research 22:8, pages 3991-4000.
Crossref
Crossref
Preet Anand & Baldev Singh. (2012) Flavonoids as lead compounds modulating the enzyme targets in Alzheimer’s disease. Medicinal Chemistry Research 22:7, pages 3061-3075.
Crossref
Crossref
Yiquan Zou, Li Li, Wuyan Chen, Tiantian Chen, Lanping Ma, Xin Wang, Bing Xiong, Yechun Xu & Jingkang Shen. (2013) Virtual Screening and Structure-Based Discovery of Indole Acylguanidines as Potent β-secretase (BACE1) Inhibitors. Molecules 18:5, pages 5706-5722.
Crossref
Crossref
Yan Niu, Haifei Gao, Fengrong Xu, Chao Wang, Peng Liu, Guanyu Yang, Qi Sun & Ping Xu. (2012)
Synthesis,
in vitro
Biological Evaluation and Molecular Docking Studies of Benzimidamides as Potential BACE1 Inhibitors
. Chemical Biology & Drug Design 80:5, pages 775-780.
Crossref
Crossref
Veronica Sandgren, Tatiana Agback, Per-Ola Johansson, Jimmy Lindberg, Ingemar Kvarnstr?m, Bertil Samuelsson, Oscar Belda & Anders Dahlgren. (2012) Highly potent macrocyclic BACE-1 inhibitors incorporating a hydroxyethylamine core: Design, synthesis and X-ray crystal structures of enzyme inhibitor complexes. Bioorganic & Medicinal Chemistry 20:14, pages 4377-4389.
Crossref
Crossref
Chih-Hsin Chen & Kun-Lin Yang. (2012) Functional protease assay using liquid crystals as a signal reporter. Biosensors and Bioelectronics 35:1, pages 174-179.
Crossref
Crossref
Haythum O. Tayeb, Hyun Duk Yang, Bruce H. Price & Frank I. Tarazi. (2012) Pharmacotherapies for Alzheimer's disease: Beyond cholinesterase inhibitors. Pharmacology & Therapeutics 134:1, pages 8-25.
Crossref
Crossref
Jung Keun Cho, Young Bae Ryu, Marcus J. Curtis-Long, Ji Young Kim, Doman Kim, Sun Lee, Woo Song Lee & Ki Hun Park. (2011) Inhibition and structural reliability of prenylated flavones from the stem bark of Morus lhou on β-secretase (BACE-1). Bioorganic & Medicinal Chemistry Letters 21:10, pages 2945-2948.
Crossref
Crossref
Derek C. Cole & Matthew G. Bursavich. 2010. Aspartic Acid Proteases as Therapeutic Targets. Aspartic Acid Proteases as Therapeutic Targets
481
509
.
Hong Zhu, Mary B. Young, Philippe G. Nantermet, Samuel L. Graham, Dennis Colussi, Ming-Tain Lai, Beth Pietrak, Eric A. Price, Sethu Sankaranarayanan, Xiao-ping Shi, Katherine Tugusheva, Marie A. Holahan, Maria S. Michener, Jacquelynn J. Cook, Adam Simon, Daria J. Hazuda, Joseph P. Vacca & Hemaka A. Rajapakse. (2010) Rapid P1 SAR of brain penetrant tertiary carbinamine derived BACE inhibitors. Bioorganic & Medicinal Chemistry Letters 20:5, pages 1779-1782.
Crossref
Crossref
Catarina Björklund, Stefan Oscarson, Kurt Benkestock, Neera Borkakoti, Katarina Jansson, Jimmy Lindberg, Lotta Vrang, Anders Hallberg, Åsa Rosenquist & Bertil Samuelsson. (2010) Design and Synthesis of Potent and Selective BACE-1 Inhibitors. Journal of Medicinal Chemistry 53:4, pages 1458-1464.
Crossref
Crossref
Yu-Sen Wang, Corey Strickland, Johannes H. Voigt, Matthew E. Kennedy, Brian M. Beyer, Mary M. Senior, Elizabeth M. Smith, Terry L. Nechuta, Vincent S. Madison, Michael Czarniecki, Brian A. McKittrick, Andrew W. Stamford, Eric M. Parker, John C. Hunter, William J. Greenlee & Daniel F. Wyss. (2009) Application of Fragment-Based NMR Screening, X-ray Crystallography, Structure-Based Design, and Focused Chemical Library Design to Identify Novel μM Leads for the Development of nM BACE-1 (β-Site APP Cleaving Enzyme 1) Inhibitors. Journal of Medicinal Chemistry 53:3, pages 942-950.
Crossref
Crossref
Paula Grammas. 2011. Therapeutic Angiogenesis for Vascular Diseases. Therapeutic Angiogenesis for Vascular Diseases
295
312
.
Fabienne Hoffmann-Emery, Roland Jakob-Roetne, Alexander Flohr, Fritz Bliss & Reinhard Reents. (2009) Improved synthesis of (S)-7-amino-5H,7H-dibenzo[b,d]azepin-6-one, a building block for γ-secretase inhibitors. Tetrahedron Letters 50:46, pages 6380-6382.
Crossref
Crossref
Roland Jakob-Roetne & Helmut Jacobsen. (2009) Alzheimer's Disease: From Pathology to Therapeutic Approaches. Angewandte Chemie International Edition 48:17, pages 3030-3059.
Crossref
Crossref
Roland Jakob-Roetne & Helmut Jacobsen. (2009) Die Alzheimer-Demenz: von der Pathologie zu therapeutischen Ansätzen. Angewandte Chemie 121:17, pages 3074-3105.
Crossref
Crossref
Wen‐Lian Wu & Lili Zhang. (2009) γ‐secretase inhibitors for the treatment of Alzheimer's disease. Drug Development Research 70:2, pages 94-100.
Crossref
Crossref
Philippe G. Nantermet, Hemaka A. Rajapakse, Mathew G. Stanton, Shaun R. Stauffer, James C. Barrow, Allison R. Gregro, Keith P. Moore, Melissa A. Steinbeiser, John Swestock, Harold G. Selnick, Samuel L. Graham, Georgia B. McGaugheyDennis ColussiMing‐Tain LaiSethu SankaranarayananAdam J. SimonSanjeev MunshiJacquelynn J. CookMarie A. HolahanMaria S. MichenerJoseph P. Vacca. (2009) Evolution of Tertiary Carbinamine BACE‐1 Inhibitors: Aβ Reduction in Rhesus CSF upon Oral Dosing. ChemMedChem 4:1, pages 37-40.
Crossref
Crossref
Eugenia Teodor, Wanda Buzgariu, Alexandrina Rugina, Mirela Diaconu & G. L. Radu. 2009. Innovations in Chemical Biology. Innovations in Chemical Biology
353
360
.
Michael S Wolfe. (2008) Selective amyloid-β lowering agents. BMC Neuroscience 9:S2.
Crossref
Crossref
Dimitri Semizarov & Eric Blomme. 2008. Genomics in Drug Discovery and Development. Genomics in Drug Discovery and Development
219
291
.
David H. Small, David W. Klaver & Marie Beckman. (2008) Regulation of proBACE1 by Glycosaminoglycans. Neurodegenerative Diseases 5:3-4, pages 206-208.
Crossref
Crossref
Wang-Xia Wang, Bernard W. Rajeev, Arnold J. Stromberg, Na Ren, Guiliang Tang, Qingwei Huang, Isidore Rigoutsos & Peter T. Nelson. (2008) The Expression of MicroRNA miR-107 Decreases Early in Alzheimer's Disease and May Accelerate Disease Progression through Regulation of β-Site Amyloid Precursor Protein-Cleaving Enzyme 1. The Journal of Neuroscience 28:5, pages 1213-1223.
Crossref
Crossref
A. Jackie Hunter. 2008. Animal and Translational Models for CNS Drug Discovery. Animal and Translational Models for CNS Drug Discovery
1
20
.
Alessandra Barazza, Marion Götz, Sergio A. Cadamuro, Peter Goettig, Michael Willem, Holger Steuber, Tanja Kohler, Anja Jestel, Peter Reinemer, Christian Renner, Wolfram Bode & Luis Moroder. (2007) Macrocyclic Statine-Based Inhibitors of BACE-1. ChemBioChem 8:17, pages 2078-2091.
Crossref
Crossref
Keith P. Moore, Hong Zhu, Hemaka A. Rajapakse, Georgia B. McGaughey, Dennis Colussi, Eric A. Price, Sethu Sankaranarayanan, Adam J. Simon, Nicole T. Pudvah, Jerome H. Hochman, Timothy Allison, Sanjeev K. Munshi, Samuel L. Graham, Joseph P. Vacca & Philippe G. Nantermet. (2007) Strategies toward improving the brain penetration of macrocyclic tertiary carbinamine BACE-1 inhibitors. Bioorganic & Medicinal Chemistry Letters 17:21, pages 5831-5835.
Crossref
Crossref
Sascha Weggen, Mark Rogers & Jason Eriksen. (2007) NSAIDs: small molecules for prevention of Alzheimer's disease or precursors for future drug development?. Trends in Pharmacological Sciences 28:10, pages 536-543.
Crossref
Crossref
Eva Czirr, Stefanie Leuchtenberger, Cornelia Dorner-Ciossek, Anna Schneider, Mathias Jucker, Edward H. Koo, Claus U. Pietrzik, Karlheinz Baumann & Sascha Weggen. (2007) Insensitivity to Aβ42-lowering Nonsteroidal Anti-inflammatory Drugs and γ-Secretase Inhibitors Is Common among Aggressive Presenilin-1 Mutations*. Journal of Biological Chemistry 282:34, pages 24504-24513.
Crossref
Crossref
Matthew G. Stanton, Shaun R. Stauffer, Alison R. Gregro, Melissa Steinbeiser, Philippe Nantermet, Sethu Sankaranarayanan, Eric A. Price, Guoxin Wu, Ming-Chih Crouthamel, Joan Ellis, Ming-Tain Lai, Amy S. Espeseth, Xiao-Ping Shi, Lixia Jin, Dennis Colussi, Beth Pietrak, Qian Huang, Min Xu, Adam J. Simon, Samuel L. Graham, Joseph P. Vacca & Harold Selnick. (2007) Discovery of Isonicotinamide Derived β-Secretase Inhibitors: In Vivo Reduction of β-Amyloid. Journal of Medicinal Chemistry 50:15, pages 3431-3433.
Crossref
Crossref
Stacey R. Lindsley, Keith P. Moore, Hemaka A. Rajapakse, Harold G. Selnick, Mary Beth Young, Hong Zhu, Sanjeev Munshi, Lawrence Kuo, Georgia B. McGaughey, Dennis Colussi, Ming-Chih Crouthamel, Ming-Tain Lai, Beth Pietrak, Eric A. Price, Sethu Sankaranarayanan, Adam J. Simon, Guy R. Seabrook, Daria J. Hazuda, Nicole T. Pudvah, Jerome H. Hochman, Samuel L. Graham, Joseph P. Vacca & Philippe G. Nantermet. (2007) Design, synthesis, and SAR of macrocyclic tertiary carbinamine BACE-1 inhibitors. Bioorganic & Medicinal Chemistry Letters 17:14, pages 4057-4061.
Crossref
Crossref
Todd E. Golde, Criag Zwizinski & Andrew Nyborg. 2007. Intramembrane-Cleaving Proteases (I-CLiPs). Intramembrane-Cleaving Proteases (I-CLiPs)
17
30
.
A. Claudio CuelloSascha Weggen, Eva Czirr, Stefanie Leuchtenberger & Jason Eriksen. 2007. Pharmacological Mechanisms in Alzheimer's Therapeutics. Pharmacological Mechanisms in Alzheimer's Therapeutics
167
193
.
Eva Czirr & Sascha Weggen. (2006) γ-Secretase Modulation with Aβ42-Lowering Nonsteroidal Anti-Inflammatory Drugs and Derived Compounds. Neurodegenerative Diseases 3:4-5, pages 298-304.
Crossref
Crossref
Shawn J. Stachel, Craig A. Coburn, Sethu Sankaranarayanan, Eric A. Price, Beth L. Pietrak, Qian Huang, Janet Lineberger, Amy S. Espeseth, Lixia Jin, Joan Ellis, M. Katharine Holloway, Sanjeev Munshi, Timothy Allison, Daria Hazuda, Adam J. Simon, Samuel L. Graham & Joseph P. Vacca. (2006) Macrocyclic Inhibitors of β-Secretase: Functional Activity in an Animal Model. Journal of Medicinal Chemistry 49:21, pages 6147-6150.
Crossref
Crossref
Alicia Torrado. (2006) Stereoselective synthesis of aminoethylamine aspartyl protease transition state isosteres. Tetrahedron Letters 47:39, pages 7097-7100.
Crossref
Crossref
Andrew C. Nyborg, Thomas B. Ladd, Karen Jansen, Thomas Kukar & Todd E. Golde. (2006) Intramembrane proteolytic cleavage by human signal peptide peptidase like 3 and malaria signal peptide peptidase. The FASEB Journal 20:10, pages 1671-1679.
Crossref
Crossref
Craig A. Coburn, Shawn J. Stachel, Kristen G. Jones, Thomas G. Steele, Diane M. Rush, Jillian DiMuzio, Beth L. Pietrak, Ming-Tain Lai, Qian Huang, Janet Lineberger, Lixia Jin, Sanjeev Munshi, M. Katharine Holloway, Amy Espeseth, Adam Simon, Daria Hazuda, Samuel L. Graham & Joseph P. Vacca. (2006) BACE-1 inhibition by a series of ?[CH2NH] reduced amide isosteres. Bioorganic & Medicinal Chemistry Letters 16:14, pages 3635-3638.
Crossref
Crossref
Daniela Puzzo, Agostino Palmeri & Ottavio Arancio. (2006) Involvement of the Nitric Oxide Pathway in Synaptic Dysfunction Following Amyloid Elevation in Alzheimer's Disease. Reviews in the Neurosciences 17:5.
Crossref
Crossref
Katleen Dillen & Wim Annaert. 2006.
215
300
.